176 related articles for article (PubMed ID: 7947896)
1. Tolerance of peripheral veins to antithymocyte globulin after heart transplantation.
Cantarovich M; Latter DA
J Heart Lung Transplant; 1994; 13(4):737. PubMed ID: 7947896
[No Abstract] [Full Text] [Related]
2. Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
Wei J; Chang CY; Lee FY; Song YB; Jiau SF
Transplant Proc; 1992 Aug; 24(4):1493-7. PubMed ID: 1496632
[No Abstract] [Full Text] [Related]
3. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
Fasola CG; Hricik DE; Schulak JA
Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
[No Abstract] [Full Text] [Related]
4. Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute.
Beaufigeau M; Dumesnil D; Carrier M; White M; Pelletier GB
Transplant Proc; 1997 Nov; 29(7A):10S-12S. PubMed ID: 9366918
[No Abstract] [Full Text] [Related]
5. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases.
Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807
[TBL] [Abstract][Full Text] [Related]
6. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation.
Carrier M; Pelletier GB; Cartier R; Leclerc Y; Robitaille D; Pelletier LC
Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788
[TBL] [Abstract][Full Text] [Related]
7. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
Thomas F; Mendez-Picon G; Thomas J; Lee HM
Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
[No Abstract] [Full Text] [Related]
8. Reversal of rejection-induced coronary vasculitis detected early after heart transplantation with increased immunosuppression.
Ballester M; Obrador D; Carrió I; Bordes R; Augé JM; Crexells C; Oriol A; Padró JM; Arís A; Caralps JM
J Heart Transplant; 1989; 8(5):413-7. PubMed ID: 2795284
[TBL] [Abstract][Full Text] [Related]
9. Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression.
Snow MH; Cannella AC; Stevens RB; Mikuls TR
Arthritis Rheum; 2009 Sep; 61(9):1271-4. PubMed ID: 19714613
[No Abstract] [Full Text] [Related]
10. Survival of tumor allografts in rats treated with antithymocyte serum.
Abandowitz HM; Basrur PK
Z Naturforsch C; 1973; 28(9):631-2. PubMed ID: 4272308
[No Abstract] [Full Text] [Related]
11. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
Delmonico FL
Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
[No Abstract] [Full Text] [Related]
12. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
13. Alterations in T and B lymphocytes in heart transplant patients early and late postoperatively.
Khalaf TH; Strober S; Garrelts G; Stinson EB
J Clin Invest; 1976 Jul; 58(1):212-20. PubMed ID: 777028
[TBL] [Abstract][Full Text] [Related]
14. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
15. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
Renlund DG; O'Connell JB; Bristow MR
J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767
[No Abstract] [Full Text] [Related]
16. The effect of antithymocyte globulin therapy on frequency and avidity of allospecific committed CTL in clinical heart transplants.
Baan CC; Vaessen LM; Loonen EH; Balk AH; Jutte NH; Claas FH; Weimar W
Transplant Proc; 1995 Feb; 27(1):482-4. PubMed ID: 7879069
[No Abstract] [Full Text] [Related]
17. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients.
Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I
Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
[No Abstract] [Full Text] [Related]
19. Individualization of recipient immunosuppression by use of in vitro monitoring parameters.
Thomas F; Thomas J; Mendez G; Lee HM; Lower R
Transplant Proc; 1978 Sep; 10(3):621-5. PubMed ID: 362647
[No Abstract] [Full Text] [Related]
20. Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation.
Wollenek G; Laufer G; Laczkovics A; Buxbaum P; Kober I
Transplant Proc; 1989 Feb; 21(1 Pt 3):2499-501. PubMed ID: 2495642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
